Hochschulschrift
Mechanism of cancer evading metronomic chemotherapy and action of archazolid as an anti-metastatic drug
- Sprache
-
Englisch
- Umfang
-
108 S.
- Maße
-
30 cm
- Anmerkungen
-
Ill., graph. Darst.
München, Univ., Diss., 2013 (Nicht für den Austausch)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Klassifikation
-
Medizin, Gesundheit
Biowissenschaften, Biologie
- Urheber
-
Kubisch, Rebekka
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.03.2025, 12:03 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Kubisch, Rebekka
Ähnliche Objekte (12)
Mechanism of cancer evading metronomic chemotherapy and action of Archazolid as an anti-metastatic drug
Molecular mechanism of early metastatic breast cancer dissemination
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups
Fractionated follow-up chemotherapy delays the onset of resistance in bone metastatic prostate cancer
Antiviral drugs : mode of action and chemotherapy of viral infections of man
Speciation analysis of platinum-based chemotherapy drugs in human blood
Topics on cancer chemotherapy : proceedings of the Internat. Symposium on Adriamycin and Other Drugs in Antitumor Chemotherapy
Evolution of RAS mutational status in liquid biopsies during first-line chemotherapy for metastatic colorectal cancer
Chemotherapy of Tumors
53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients
Allosteric drug transport mechanism of multidrug transporter AcrB
Passive drug loading of lipid nanocarriers : investigations on loading mechanism and drug solubility
Mechanism of cancer evading metronomic chemotherapy and action of Archazolid as an anti-metastatic drug
Molecular mechanism of early metastatic breast cancer dissemination
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups
Fractionated follow-up chemotherapy delays the onset of resistance in bone metastatic prostate cancer
Antiviral drugs : mode of action and chemotherapy of viral infections of man
Speciation analysis of platinum-based chemotherapy drugs in human blood
Topics on cancer chemotherapy : proceedings of the Internat. Symposium on Adriamycin and Other Drugs in Antitumor Chemotherapy
Evolution of RAS mutational status in liquid biopsies during first-line chemotherapy for metastatic colorectal cancer
Chemotherapy of Tumors
53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients
Allosteric drug transport mechanism of multidrug transporter AcrB
Passive drug loading of lipid nanocarriers : investigations on loading mechanism and drug solubility
Mechanism of cancer evading metronomic chemotherapy and action of Archazolid as an anti-metastatic drug
Molecular mechanism of early metastatic breast cancer dissemination
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups
Fractionated follow-up chemotherapy delays the onset of resistance in bone metastatic prostate cancer
Antiviral drugs : mode of action and chemotherapy of viral infections of man
Speciation analysis of platinum-based chemotherapy drugs in human blood
Topics on cancer chemotherapy : proceedings of the Internat. Symposium on Adriamycin and Other Drugs in Antitumor Chemotherapy
Evolution of RAS mutational status in liquid biopsies during first-line chemotherapy for metastatic colorectal cancer
Chemotherapy of Tumors
53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients
Allosteric drug transport mechanism of multidrug transporter AcrB